ArticleEuropean urology open science2024

Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.

Margaret F Meagher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.